- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2-specific T cells in infection and vaccination
Authors
Keywords
-
Journal
Cellular & Molecular Immunology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-01
DOI
10.1038/s41423-021-00743-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
- (2021) Rogan A. Grant et al. NATURE
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
- (2021) Anthony T. Tan et al. Cell Reports
- Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
- (2021) Catherine J. Reynolds et al. Science Immunology
- COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses
- (2021) Agnes Bonifacius et al. IMMUNITY
- Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19
- (2021) Peter A. Szabo et al. IMMUNITY
- Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
- (2021) Nina Le Bert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Persistent cellular immunity to SARS-CoV-2 infection
- (2021) Gaëlle Breton et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
- (2021) Maria Prendecki et al. LANCET
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
- (2021) Ester C Sabino et al. LANCET
- Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
- (2021) Jianmin Zuo et al. NATURE IMMUNOLOGY
- Immunity to SARS-CoV-2 variants of concern
- (2021) Daniel M. Altmann et al. SCIENCE
- Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia
- (2021) Stefanie Kreutmair et al. IMMUNITY
- Single-cell multi-omics analysis of the immune response in COVID-19
- (2021) Emily Stephenson et al. NATURE MEDICINE
- Delayed production of neutralizing antibodies correlates with fatal COVID-19
- (2021) Carolina Lucas et al. NATURE MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
- (2021) Catherine J. Reynolds et al. SCIENCE
- Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection
- (2021) Zhongfang Wang et al. Nature Communications
- SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
- (2021) Alba Grifoni et al. Cell Host & Microbe
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
- (2021) Nawal Al Kaabi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity
- (2021) William E. Matchett et al. JOURNAL OF IMMUNOLOGY
- SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
- (2021) Jackson S. Turner et al. NATURE
- Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
- (2021) Dami A. Collier et al. NATURE
- Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
- (2021) Galit Alter et al. NATURE
- BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
- (2021) Ugur Sahin et al. NATURE
- CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
- (2021) Erin M. Bange et al. NATURE MEDICINE
- Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
- (2021) Mark G. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care
- (2021) Clemens Gutmann et al. Nature Communications
- Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy
- (2021) Josè Vitale et al. JAMA Internal Medicine
- SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
- (2021) Daryl Geers et al. Science Immunology
- Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
- (2021) Wan Ni Chia et al. Lancet Microbe
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover
- (2020) Annarosa Soresina et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients
- (2020) J.M. Urra et al. CLINICAL IMMUNOLOGY
- Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
- (2020) Alessio Mazzoni et al. JOURNAL OF CLINICAL INVESTIGATION
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran
- (2020) Farinaz Safavi et al. Multiple Sclerosis and Related Disorders
- Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
- (2020) Paloma Montero-Escribano et al. Multiple Sclerosis and Related Disorders
- SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection
- (2020) Daniel M. Altmann et al. Science Immunology
- Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome
- (2020) Daniela Weiskopf et al. Science Immunology
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19
- (2020) Benjamin J. Meckiff et al. CELL
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response
- (2020) Kanagavel Murugesan et al. CLINICAL INFECTIOUS DISEASES
- A whole blood test to measure SARS-CoV-2 specific response in COVID-19 patients
- (2020) Linda Petrone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2, most of which are not located in the Spike protein
- (2020) Andrew P. Ferretti et al. IMMUNITY
- Kinetics of viral load and antibody response in relation to COVID-19 severity
- (2020) Yanqun Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Sex differences in immune responses that underlie COVID-19 disease outcomes
- (2020) Takehiro Takahashi et al. NATURE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
- (2020) Angkana T. Huang et al. Nature Communications
- Two distinct immunopathological profiles in autopsy lungs of COVID-19
- (2020) Ronny Nienhold et al. Nature Communications
- High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
- (2020) David Schub et al. JCI Insight
- Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
- (2020) Lauren B. Rodda et al. CELL
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients
- (2020) Changfu Yao et al. Cell Reports
- Intrahepatic CD206 + macrophages contribute to inflammation in advanced viral-related liver disease
- (2017) Alfonso Tan-Garcia et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started